 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Christopher Lieu and Breelyn Wilky.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.119 |
|
|
|
-
El-Khoueiry AB, Lieu CH, Abou-Alfa GK, Tsimberidou AM, Mahadevan D, Hanna DL, Bockorny B, Wilky BA, Leal A, Stebbing J, Avagyan M, Wu W, Chand D, Grossman JE, Johnson B, Bullock AJ. A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma. Liver Cancer. 2026 Mar 30.
Score: 0.061
-
Alsafar A, Kareem SL, Corr BR, Lieu CH, Wilky B, Davis SL, Camidge DR, Jimeno A, Messersmith WA, Nicklawsky A, Pacheco D, Borrayo EA, McDermott JD, Diamond JR. Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center. Front Oncol. 2025; 15:1546500.
Score: 0.058
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|